PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
about
Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitroNO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medicationCurcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial CellsProstaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticusRole of the prostaglandin E2 EP1 receptor in traumatic brain injuryLoss of the PGE2 receptor EP1 enhances bone acquisition, which protects against age and ovariectomy-induced impairments in bone strength.Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity.Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors.Prostaglandin E2 type 1 receptors contribute to neuronal apoptosis after transient forebrain ischemia.Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity.Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideUntangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Suppression of Alzheimer-associated inflammation by microglial prostaglandin-E2 EP4 receptor signaling.Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer's DiseaseHippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.Activation of EP2 receptor suppresses poly(I: C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs.Animal Models of Posttraumatic Seizures and Epilepsy.Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.
P2860
Q26861848-404F4930-6106-4300-A226-265F825C6CC1Q27334947-C841F75B-3E0D-4675-8153-70354E009289Q28552971-6E5A0587-9625-4B6E-A8B8-1C85D780DFBFQ30634663-FB16B729-B691-4879-9F27-6703EDF916D9Q33832795-9EF1C6BC-9804-4310-9F03-454D183EA519Q34036388-14DD0465-CE11-4E60-A807-0831624BBF64Q34576460-91BB3C38-7529-4E8F-918E-F94F7C1585B9Q35624009-24C61D3D-F4FF-44DE-8646-2373CA506600Q35732404-111BC5E3-9F83-4B63-B13D-2EC133BF1F52Q35993214-6E54AF02-1F7A-4898-BE23-438D551F99ABQ36152287-96A53545-AFB3-42B0-ABBE-2B0855500511Q36379542-2F9E79C2-4BF1-4338-B0E8-462C269E088EQ37073393-8EEEA14B-D477-4C2B-BD9A-125E389468C4Q37217431-0A284E9A-8759-419E-87A3-164B3AF32A5CQ37340703-7CB268A7-39A7-40F9-A7A2-DE564507F221Q37588183-644D5F6E-DE16-41E3-AC53-6E4155ECF381Q37678539-9A1BA4A7-6FF5-41D3-9D73-32269E569013Q37717636-993EC875-552D-4543-A7CF-576B5F2A063BQ37741526-55614CD1-AE4F-49DD-9EA8-AB2817ED7A19Q43157877-234614FD-7B66-407A-954C-486C326EFDBDQ45295696-02312D06-8E83-4CD4-997A-67250C0F27CFQ47309400-DB4A75F3-8768-41C0-9438-1BB767F800D4Q48525202-E95CAD14-90C9-4375-8C13-7C7AD625BE8FQ50526982-B13A0A1D-563B-4E6C-B49F-BDE2FC78C4FCQ51741486-D112DEFF-D6C7-4834-84FB-A204560FD808
P2860
PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@ast
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@en
type
label
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@ast
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@en
prefLabel
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@ast
PGE2 EP1 receptor exacerbated ...... hemia and Alzheimer's disease.
@en
P2093
P2860
P921
P1476
PGE2 EP1 receptor exacerbated ...... chemia and Alzheimer's disease
@en
P2093
Gehua Zhen
Jennifer Yocum
John Langer
Nidhi Kapoor
Peter Dobrowolski
Rung-chi Li
Shuh Narumiya
Takayuki Maruyama
Yun Tai Kim
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2011.09.017
P50
P577
2011-10-19T00:00:00Z